Skip to main content
Clinical Trials/CTRI/2023/10/059302
CTRI/2023/10/059302
Not yet recruiting
Phase 2

Role of Homoeopathy Medicine In Dysfunctional Uterine Bleeding with utility of Synthesis repertory for such Cases - NI

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N921- Excessive and frequent menstruation with irregular cycleHealth Condition 2: N924- Excessive bleeding in the premenopausal periodHealth Condition 3: N922- Excessive menstruation at puberty
Sponsor
I
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • Female Patients Between 18\-45 Years of Age.
  • Female Patients Suffering from Dysfunctional Uterine Bleeding along with some other Hormonal Diseases, Stress Disorders which may effect hormonal level.

Exclusion Criteria

  • Advance and Irreversible or any kind of Pelvic Pathological Conditions are excluded.
  • Cases with Systemic, Iatrogenic, Organic Pathology.Drop out Cases.
  • Cases with Irregular Follow Ups.

Outcomes

Primary Outcomes

Not specified

Similar Trials